Avaleht › Ülekaalulisus › Alabama

Ülekaalulisus kliinilised uuringud osariigis Alabama

31 uuringut haiguse Ülekaalulisus jaoks otsivad osalejaid osariigis Alabama.

Linnad osariigis Alabama

Ametlik uuringutekst (inglise keeles)

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Cahaba Research - Pelham /ID# 282381, Pelham

VärbamineFaas 2

Vanused 18–75 · Kõik sood · Uuendatud 2. okt 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Univ of Alabama Birmingham, Birmingham

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 30. sept 2026 · NCT07533175

A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)

Cullman Clinical Trials, Cullman

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07823608

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

AMR Clinical - Mobile, Mobile

VärbamineFaas 2

Vanused 18 ja vanemad · Kõik sood · Uuendatud 29. sept 2026 · NCT07685808

Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss

University of Alabama - Birmingham, Birmingham

VärbamineFaas 2

Vanused 18–75 · Kõik sood · Uuendatud 28. sept 2026 · NCT07837973

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Pinnacle Research Group LLC, Anniston
Univ of Alabama Birmingham, Birmingham
Chambliss Clinical Trials LLC, Montgomery

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07720271

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Pinnacle Research Group, LLC, Anniston
Central Research Associates, Birmingham
Cahaba Research - Pelham, Pelham

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 28. sept 2026 · NCT07794579

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Digestive Health Specialists, Dothan

VärbamineFaas 3

Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937099

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Digestive Health Specialists, Dothan

VärbamineFaas 3

Vanused 18–70 · Kõik sood · Uuendatud 24. sept 2026 · NCT06937086

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Birmingham Clinical Research, Birmingham
Cullman Clinical Trials, Cullman

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Birmingham Clinical Research, Birmingham

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Research Site, Fairhope
Research Site, Huntsville
Research Site, Mobile

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Cullman Clinical Trials, Cullman

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Alliance For Multispecialty Research - Daphne, Daphne
Eastern Shore Research Institute, Fairhope
Heart Center Research LLC, Huntsville
ja veel 2

VärbamineFaas 3

Vanused 45–99 · Kõik sood · Uuendatud 22. sept 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

MFA Clinical Research, Tuscaloosa

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

AMR Clinical, Mobile

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 22. sept 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

AURORA-1 Clinical Site, Birmingham
AURORA-1 Clinical Site, Huntsville

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

AURORA-2 Clinical Site, Birmingham
AURORA-2 Clinical Site, Huntsville

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 16. sept 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Lakeview Clinical Research, Guntersville

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351058

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Pinnacle Research Group, Anniston
Alabama Clinical Therapeutics, Birmingham
University of Alabama at Birmingham, Birmingham

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 14. sept 2026 · NCT07351045

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

ACCOMPLISH-2 Research Site, Birmingham

VärbamineFaas 3Terved vabatahtlikud oodatud

Vanused 18–79 · Kõik sood · Uuendatud 11. sept 2026 · NCT07654374

Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight

Uni of Alabama at Birmingham, Birmingham

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 9. sept 2026 · NCT07770841

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

Kailera Clinical Site, Cullman

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Pinnacle Research Group LLC, Anniston
Alliance For Multispecialty Research - Daphne, Daphne
Alliance for Multispecialty Research Mobile, Mobile

VärbamineFaas 3

Vanused 18–99 · Kõik sood · Uuendatud 3. sept 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Kailera Clinical Site, Anniston
Kailera Clinical Site, Birmingham
Kailera Clinical Site, Cullman

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 3. sept 2026 · NCT07284875

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Cahaba Research, Inc., Pelham

VärbamineFaas 3

Vanused 18–99 · Kõik sood · Uuendatud 27. aug 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Research Site, Dothan
Research Site, Huntsville

VärbamineFaas 3

Vanused 18 ja vanemad · Kõik sood · Uuendatud 25. aug 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

ACCOMPLISH-1 Research Site, Birmingham
ACCOMPLISH-1 Research Site, Birmingham

VärbamineFaas 3

Vanused 18–79 · Kõik sood · Uuendatud 10. aug 2026 · NCT07654361

Time-restricted Eating for Postpartum Weight Loss

University of Alabama at Birmingham, Birmingham

Värbamine

Vanused 18 ja vanemad · Naised · Uuendatud 29. juuni 2026 · NCT06491537

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

University of Alabama at Birmingham, Birmingham

Värbamine

Vanused 18–45 · Naised · Uuendatud 24. juuni 2026 · NCT05124808

FELLAShip to Better Health

The Worship Center Cristian Church, Birmingham

Värbamine

Vanused 18 ja vanemad · Mehed · Uuendatud 22. jaan 2026 · NCT07220213

Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.